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Abstract
Background: Pseudomonas aeruginosa, a non-fermentative, gram-negative rod, is responsible for a wide
variety of clinical syndromes in NICU patients, including sepsis, pneumonia, meningitis, diarrhea,
conjunctivitis and skin infections. An increased number of infections and colonisations by P. aeruginosa has
been observed in the neonatal intensive care unit (NICU) of our university hospital between 2005 and
2007.
Methods: Hand disinfection compliance before and after an educational programme on hand hygiene was
evaluated. Identification of microrganisms was performed using conventional methods. Antibiotic
susceptibility was evaluated by MIC microdilution. Genotyping was performed by PFGE analysis.
Results: The molecular epidemiology of Pseudomonas aeruginosa in the NICU of the Federico II University
hospital (Naples, Italy) and the infection control measures adopted to stop the spreading of P. aeruginosa
in the ward were described. From July 2005 to June 2007, P. aeruginosa was isolated from 135 neonates
and caused severe infections in 11 of them. Macrorestriction analysis of clinical isolates from 90 neonates
identified 20 distinct genotypes, one major PFGE type (A) being isolated from 48 patients and responsible
for 4 infections in 4 of them, four other distinct recurrent genotypes being isolated in 6 to 4 patients. Seven
environmental strains were isolated from the hand of a nurse and from three sinks on two occasions, two
of these showing PFGE profiles A and G identical to two clinical isolates responsible for infection. The
successful control of the outbreak was achieved through implementation of active surveillance of
healthcare-associated infections in the ward together with environmental microbiological sampling and an
intense educational programme on hand disinfection among the staff members.
Conclusion: P. aeruginosa infections in the NICU were caused by the cross-transmission of an epidemic
clone in 4 neonates, and by the selection of sporadic clones in 7 others. An infection control programme
that included active surveillance and strict adherence to hand disinfection policies was effective in
controlling NICU-acquired infections and colonisations caused by P. aeruginosa.
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Background
Gram-negative bacteria have become relevant causes of
healthcare-associated infections in the neonatal intensive
care unit (NICU) environment. [1,2]. Outbreaks by
Enterobacteriaceae have been widely described in this set-
ting [3], and we recently reported the increased circulation
of ESBL-producing Klebsiella pneumoniae and  Serratia
marcescens in the NICU of the Federico II University Hos-
pital of Naples between 2002 and 2004 [4,5].
Pseudomonas aeruginosa, a non-fermentative, gram-nega-
tive rod, is responsible for a wide variety of clinical syn-
dromes in NICU patients, including sepsis, pneumonia,
meningitis, diarrhea, conjunctivitis and skin infections
[6]. Nevertheless, if compared to other gram-negative bac-
teria, outbreaks by P. aeruginosa in NICU settings have
been much less reported up-to-date and have been associ-
ated with both environmental reservoirs and healthcare
workers' carriage [7-10].
An increased number of infections and colonisations by P.
aeruginosa has been observed in the NICU of our univer-
sity hospital between 2005 and 2007. The aims of this
study were: i) to analyze the molecular epidemiology and
antimicrobial susceptibility patterns of P. aeruginosa iso-
lates; ii) to describe the infection control measures under-
taken to limit P. aeruginosa spread in the ward.
Methods
Setting and surveillance measures
The tertiary-level NICU of the University 'Federico II' hos-
pital of Naples, Italy serves approximately 350 admissions
per year including both inborn and outborn patients and
consists of three rooms with a maximum capacity of eight
neonates per room. Sinks, chlorhexidine/alcohol hand
disinfectants and gloves are available in each room. Sinks,
4% chlorhexidine hand disinfectants, and gloves are avail-
able in each room, together with hand disinfection
instructions for staff members and visiting parents.
Healthcare-associated infections were defined using
standard Centers for Disease Control and Prevention def-
initions adapted to neonatal pathology [11]. Infections
occurring after 48 hours of hospital stay were assumed to
be hospital-acquired, those resulting from passage
through the birth canal or from transplacentar transmis-
sion were excluded. For this study purposes, only severe
infections (sepsis, meningitis, arthritis, pneumonia, uri-
nary tract infections) were considered. Surveillance swabs
from the nose/pharynx and rectum of each neonate
admitted to the ward were analysed weekly. Informed
consent to participate in this study was obtained from
patients' parents. The study protocol was reviewed and
approved by the local ethics committee. P. aeruginosa iso-
lated from surveillance swabs and from clinical samples
(blood, liquor, respiratory secretions, urine) of babies in
the NICU were included in the study. Environmental sam-
ples were obtained from the following sites: air, room sur-
faces, sinks, hand disinfectants, baby incubators,
monitors, and staff hands. All three sinks present in the
ward were sampled.
Hand disinfection educational programme
An educational programme on hand disinfection was
repeatedly performed as part of the ward's plan for health-
care-associated infections control. It involved both medi-
cal and nursing staffs, it was carried out each time for one
week, and it consisted of a 30 minutes review of the main
topics on hand disinfection according to the US Centers
for Disease Control and Prevention (CDC) recommenda-
tions [12]. Hand disinfection reminders were placed near
each sink.
Hand disinfection compliance evaluation and statistical 
analysis
Hand disinfection compliance was defined as hand-wash-
ing with the appropriate quantity of 4% chlorhexidine
disinfectant and water for the recommended time, before
and after each patient contact and it was evaluated by car-
rying out an observational study. Moreover, surveillance
cultures from 30 randomly selected healthcare workers'
hands were obtained by means of contact plates before
and after each educational programme.
A trained, disguised observer monitored staff's (doctors
and nurses) compliance to hand disinfection for the two
weeks preceding and the two weeks following each series
of educational meetings. Four patients were randomly
selected each day (Monday through Friday) and all
healthcare workers (HCWs) who cared for the target
neonates were observed for 1 hour period during morning
shifts and their compliance to hand disinfection proce-
dures before and after each patient contact was recorded
on a dedicated form.
Data were analysed using SPSS 11.0 (Chicago, IL, USA).
Pearson's Chi-squared test was used to compare hand
hygiene compliance before the beginning of the educa-
tional programme and after the first and the last series of
educational meetings. Pearson's correlation coefficient
between hand disinfection compliance in the same peri-
ods and colonisation rates was also calculated. All results
were considered to be statistically significant at p < 0.05.
Microbiological methods
Isolates were identified using the API NE manual identifi-
cation system (bioMérieux, Marcy-L'Etoile, France) or the
Phoenix automatic system (Becton Dickinson Bioscience,
Spark, MD, USA). The susceptibililty of isolates to 12
selected antimicrobials was determined by the standard
antimicrobial susceptibility methods [13]. The antimicro-BMC Infectious Diseases 2009, 9:70 http://www.biomedcentral.com/1471-2334/9/70
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bials were: amikacin, aztreonam, cefepime, cefotaxime,
ceftazidime, ciprofloxacin, gentamicin, imipenem, levo-
floxacin, meropenem, piperacillin, and piperacillin/tazo-
bactam.
Pulsed field gel electrophoresis
DNA macrorestriction with XbaI enzyme and pulsed-field
gel electrophoresis (PFGE) was performed on all P. aerugi-
nosa infection isolates and on available surveillance cul-
ture isolates as previously described [14].
Results
Epidemiology and Microbiological Features of 
Pseudomonas aeruginosa
In the two years preceding the outbreak period P. aerugi-
nosa has circulated in the ward in an endemic fashion,
being responsible for a mean colonisation rate of 10.6%
and for two ocular infections (data not shown). During
the study period (July 2005 to June 2007), 616 neonates
were prospectively surveilled for healthcare-associated
infections (90.1% of total admissions to the ward) and
568 of them had their weekly surveillance swabs taken at
least once. One hundred-thirty-five neonates (23.8% of
all the microbiologically surveilled) became colonised by
P. aeruginosa during their stay in the ward (Figure 1).
Moreover, 72 patients developed 91 severe healthcare-
associated infections, with an infection rate of 14.8%, cor-
responding to 5.94 severe infections/1000 patient-days.
During the first year of the study (July 2005 to June 2006),
9.17 severe infections/1000 patient-days were registered,
while such rate decreased to 3.24 severe infections/1000
patient-days during the second year (July 2006 to June
2007). During the study period, P. aeruginosa proved to be
the third most common pathogen responsible for severe
infections (12.1%), after Candida spp. (21.8%) and
Escherichia coli (16.8%). Moreover, no pathogen was iden-
tified in 18.8% of infants diagnosed as having an infec-
tion. P. aeruginosa was responsible for 11 severe infections
in 11 neonates, with 3 and 4 of them having their birth-
weights below 1000 and 750 grams, respectively (Figure 1
and Table 1). All of the four neonates weighing less than
750 grams died; three of them died within the first 24
hours from P. aeruginosa infection diagnosis and one died
after 11 days. In addition to isolation of P. aeruginosa from
Timing of control measures and incidence of isolation of P. aeruginosa in the NICU during the study period Figure 1
Timing of control measures and incidence of isolation of P. aeruginosa in the NICU during the study period. 
Squares and triangles represent neonates colonised or infected by P. aeruginosa, respectively. The following letters indicate the 
infection control interventions performed: A, alert surveillance for P. aeruginosa, collection of strains isolated from clinical sam-
ples, and reinforcement of contact isolation precautions; B, environmental microbiological sampling; C, reporting of PFGE anal-
yses to staff members; D, thirty minutes daily educational programme on hand disinfection carried out in the ward for one 
week.
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clinical samples (blood, respiratory secretions or urines),
all 11 infected patients had positive cultures for P. aerugi-
nosa at nasal/pharynx or rectum surveillance swabs.
Molecular typing of 90 non-repetitive isolates including
79 available colonisation strains and all 11 infection
strains (66.6% of all P. aeruginosa isolates) identified
twenty PFGE types, named A through T, which showed up
to six fragments variation in macrorestriction pattern (Fig-
ure 2 and data not shown). One predominant PFGE pro-
file (type A) was identified in 48 strains from 48 different
patients (53.3% of all typed isolates). This profile, which
was responsible for 4 infections and 44 colonisations, first
appeared in the ward in July 2005 and circulated until
April 2007. Other recurrent profiles were Q, R, J and G,
which were isolated in 6, 6, 5, and 4 patients, respectively,
and caused no infections, with the exception of profile G
(Table 1). Such PFGE profiles circulated in the ward in the
following months: PFGE profile Q was isolated from
August to September 2005, profile R during January and
February 2007, profile J in December 2005, February
2006, January 2007 and May 2007, profile G during
August, October and December 2005 and May 2007. The
other six infections were caused by sporadic PFGE types
(B, F, K, L, O, and R) (Table 1 and Figure 2). In all 11
infected patients, surveillance cultures and clinical sam-
ples showed identical PFGE profiles, thus excluding the
possibility of multiclonal infection in the same neonate
(data not shown).
With the exception of G and O PFGE profiles, all isolates
recovered from infected neonates proved to be susceptible
to aminopenicillins, ureidopenicillins, monobactams,
second-, third- and fourth-generation cephems, carbapen-
ems, fluoroquinolones, while resistant to trimethroprim-
sulphometossazole, cloramphenicols and tetracycline.
PFGE types G and O showed resistance also to imipenem
and meropenem (MIC > 8), gentamicin (MIC > 8) and
ciprofloxacin (MIC > 2); in addition, PFGE type G
appeared to be resistant to piperacillin/tazobactam (MIC
> 64/4). Moreover, such resistant profiles were responsi-
ble for two sepsis in two neonates with extremely low
birth-weight, both having a fatal outcome (Table 1).
Infection Control Interventions
After the sudden increase of infections caused by P. aeru-
ginosa during the fourth quarter of 2005, a combination of
targeted infection control measures were undertaken (Fig-
ure 1). A major concern of the infection control team was
the appearance of a multi-drug resistant P. aeruginosa phe-
notype in two of the three infections which took place
between October and December 2005 (Table 1).
During the first quarter of 2006 alert surveillance for P.
aeruginosa was started and contact isolation for colonised
and infected patients was reinforced. Moreover, all P. aer-
uginosa strains isolated from clinical samples and availa-
ble strains isolated from surveillance swabs were collected
for genotyping. After such control measures were imple-
mented, infection rate slightly decreased, while the rate of
colonised patients progressively increased.
Although no further isolations of multi-drug resistant P.
aeruginosa were made, tighter control interventions were
then undertaken owing to the marked increase of coloni-
sations. Environmental microbiological sampling was
performed twice during the outbreak period (Figure 1).
Reporting of PFGE analysis results was followed by a 30
minutes daily educational programme on hand disinfec-
tion. Such control measures were periodically repeated as
shown in Figure 1. The daily educational programme on
hand disinfection was not specific for P. aeruginosa con-
tainment as it was part of the ward's plan for healthcare-
associated infections control. Staff's overall attendance
Table 1: Clinical and microbiological features of P. aeruginosa isolates.
patient gestational age (weeks) birthweight (grams) type of infection outcome resistance phenotype antibio type PFGE type
TZP IPM GEN CIP
1 33,0 1950 sepsis discharge S S S S 1 B
2 26,2 790 pneumonia discharge S S S S 1 L
3 38,4 3160 pneumonia discharge S S S S 1 A
4 24,4 700 sepsis death R R R R 3 G
5 26,4 600 sepsis death S R R R 2 O
6 28,0 960 pneumonia discharge S S S S 1 K
7 36,0 2550 pneumonia discharge S S S S 1 F
8 25,2 770 pneumonia discharge S S S S 1 A
9 23,1 700 sepsis death S S S S 1 A
10 33,0 1400 U.T.I. discharge S S S S 1 R
11 30,0 650 pneumonia death S S S S 1 A
NOTE. U.T.I., Urinary tract infection; S, susceptible; R, resistant.BMC Infectious Diseases 2009, 9:70 http://www.biomedcentral.com/1471-2334/9/70
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rate was high for all the educational programme's editions
(> 90%).
Environmental microbiological sampling identified P.
aeruginosa at the following sites: three sinks on both occa-
sions and a nurse's hand on the second sampling. Geno-
typing of such strains demonstrated that the isolate
recovered from one of the sinks on the first environmental
sampling displayed an A profile and the one from the
nurse's hand on the second environmental sampling dis-
played a G profile. The other environmental isolates
showed different profiles, not corresponding to any of the
profiles isolated from patients' surveillance swabs or clin-
ical specimens.
No further targeted control measures were undertaken
after June 2007 as no other infections by P. aeruginosa
were diagnosed and colonisation rate returned to pre-epi-
demic values.
Hand disinfection compliance evaluation
P. aeruginosa of PFGE profile G was isolated only once
from surveillance cultures of a total of 90 randomly
selected healthcare workers' hands before and after each
educational programme, as described above. In addition,
other 16 surveillance cultures proved to be inappropriate
(according to the local infection control committee inap-
propriateness was defined as bacterial counts > 0.5 CFU/
cm2 in high risk wards). Hand disinfection compliance of
HCWs before the first educational programme proved to
be 23.4% and 11.7% before and after each patient con-
tact, respectively (Table 2). Such rates significantly
increased to 43.6% (p = .000) and 39.6% (p = .000),
respectively after the first intervention (Table 2). Further
significant increases were recorded after the last educa-
tional programme to 63.7% (p = .000) and to 57.1% (p =
.000), respectively (Table 2). Improvement in hand disin-
fection compliance before patient contact proved to be
very strongly, significantly, and inversely correlated with
rates of P. aeruginosa colonisation (r = -1, p = .004, data
not shown). Conversely, no significant correlation was
found between the latter and improvement in hand disin-
fection compliance after patient contact (r = -.992, p =
.081, data not shown). Finally, hand disinfection compli-
ance of HCWs before and after patient contact proved to
be significantly different at all times of observation (Table
2 and data not shown).
Discussion
The overall incidence rate of P. aeruginosa infections in
NICUs is reported to be of approximately 10% [1,2,15],
while infection attack rates during outbreak periods
appear to be lower, ranging between 1% and 2.8%
[10,16]. Higher attack rates have been reported [9,17], but
such studies did not consider infections alone and ana-
lysed the combination of infections and colonisations. At
our NICU, 11 neonates developed 11 P. aeruginosa severe
infections, with an infection attack rate of 1.8%, and
nearly 24% of the patients became colonised by P. aerugi-
nosa, with an epidemic peak of 50% at 18 months from
onset. Ten of the 11 infected patients were pre-term
neonates (gestational age < 37 weeks) and 7 of them were
of extremely low birth weight (ELBW), i.e. below 1000
grams. ELBW neonates have actually been shown to have
a significantly increased risk of acquiring P. aeruginosa
when compared to higher birth-weight infants [9]. More-
over, all of the four infected neonates who died weighed
less than 1000 grams, therefore the crude mortality rate
among ELBW patients infected by P. aeruginosa was of
57%. Although no attributable mortality rate was calcu-
lated, three of the four neonates died soon after (0–24
hours) the infection was diagnosed, thus our data indi-
rectly confirm other Authors' findings regarding the very
high mortality rates related to P. aeruginosa infections
[15], especially in the lowest birth-weight categories'
infants [18]. In our setting, in addition to the ELBW con-
dition, two P. aeruginosa antibiotypes, both displaying
resistance to imipenem, meropenem, gentamicin and cip-
rofloxacin, have probably affected the final outcome in
Representative PFGE profiles of P. aeruginosa isolates from  neonates in the NICU Figure 2
Representative PFGE profiles of P. aeruginosa isolates 
from neonates in the NICU. Capital letters on the top of 
the lanes indicate PFGE types identified; m, phage lambda 
DNA molecular mass markers. Sizes of lambda DNA molec-
ular mass markers are shown on the right of the panel.
m B O L m AAB OKBGRFm
- 242.5 kb
- 194.0 kb
- 145.5 kb
- 97.0 kb
- 48.5 kbBMC Infectious Diseases 2009, 9:70 http://www.biomedcentral.com/1471-2334/9/70
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two of the four fatal cases. We did not analyse mecha-
nisms of resistance as no further such phenotypes were
identified. Nevertheless, to our knowledge, this is one of
the first accounts on two carbapenem-resistant P. aerugi-
nosa genetically unrelated strains which caused two sepsis
in a NICU.
P. aeruginosa frequently causes multi-clone outbreaks,
with the concurrent isolation of genetically distinct strains
among patients and healthcare workers (HCWs) and in
the environment. During a 15 months-long epidemic in a
NICU, Moolenaar et al. [9] identified the three main P.
aeruginosa genotypes A, B, and C, isolated in 75%, 15%,
and 10% of case-patients, respectively. Such genotypes
were also found on three nurses' hands, while two posi-
tive environmental isolates showed two distinct geno-
types, unrelated to any human isolate. Moreover, Foca et
al. [17] described the circulation of multiple P. aeruginosa
PFGE profiles over a 33 months-period in the NICU,
showing the presence of a major clone, which was also
isolated from the hands of a nurse, of two other PFGE
types, and of eight unique clones. No environmental spec-
imen proved to be positive for P. aeruginosa. Our study,
covering a 24 months time span, identified a predomi-
nant PFGE type which was responsible for 36% of infec-
tions by P. aeruginosa and at least 35% of colonisations by
the same pathogen. Such PFGE profile was also found in
one sink, but not on any nurse's hand and circulated in
the ward together with less recurrent and with sporadic
strains, which caused the remaining infections and colo-
nisations. Other five environmental samples proved to be
positive for distinct P. aeruginosa PFGE types, unrelated to
the ones colonising or infecting the patients. Transmis-
sion of P. aeruginosa from environmental sources to
patients and HCWs has been thoroughly described
[19,20]. Our findings indicate the presence in our NICU
of multiple and distinct P. aeruginosa reservoirs, both envi-
ronmental and human, and, owing to the long time
period between the appearance in neonates (July 2005)
and the environmental isolation (2nd quarter 2006), we
are not able to understand whether the only sink sample
found to be positive for P. aeruginosa PFGE profile A has
been a result, rather than the origin, of the pathogen's cir-
culation in the ward.
Healthcare workers' (HCWs) hands have been frequently
implicated in the spreading of P. aeruginosa in the NICU
setting [9,10,17]. At our institution one HCW, with short
to medium-length natural fingernails, had a positive hand
culture for P. aeruginosa, displaying the G genotype. The
culture was drawn when the epidemic was at its peak
value, with nearly 50% of neonates being colonised. The
detection of HCWs who are colonised at any body site by
P. aeruginosa epidemic clones may sometimes identify the
pathogen's reservoir, thus enabling a successful and
timely outbreak containment [10]. Owing to organiza-
tional difficulties, the HCW found to have a positive hand
culture at our NICU could not be reassigned to non-clini-
cal activities. Moreover, no further analyses have been per-
formed to establish her contribution to the outbreak,
therefore we can only hypothesize that she has been a
transient carrier of one of the less recurrent epidemic
clones. Actually, patient exposure within the first 14 days
of NICU admission to a HCW with short natural finger-
nails and with one positive hand culture for a P. aeruginosa
epidemic clone has not been recognized as an independ-
ent risk factor for acquiring P. aeruginosa colonization or
infection [9]. In turn, exposure to two HCWs with nega-
tive hand cultures has been associated with an increased
risk of colonisation by a P. aeruginosa epidemic clone on
multivariate analysis [17]. This finding suggests that tran-
sient colonisations of HCWs' hands by P. aeruginosa may
be underestimated during outbreaks investigations and
that reinforcement of hand disinfection and of correct
gloves use should always be promptly initiated when an
increased number of P. aeruginosa isolations is detected. In
agreement with previous data [21], our study shows that,
compared with all the traditional infection control inter-
ventions undertaken to contain P. aeruginosa circulation
of in the ward, the hand disinfection educational pro-
gramme was the most effective one. The programme
started during the fourth quarter of 2006, when the out-
break was at its peak value, and by the end of the second
quarter of 2007 the outbreak was over. Owing to the pro-
gramme's success, the meaning of different hand disinfec-
tion compliance rates before and after patient contact and
how this may have affected P. aeruginosa circulation in the
ward were not further investigated. A possible explanation
for the partial ineffectiveness of the traditional infection
Table 2: Compliance with hand hygiene procedures in the NICU during the study period.
Hand disinfection observation 
period
Hand disinfection 
opportunities (n)
Compliance before 
opportunity (%)
Compliance after opportunity 
(%)
Prior to educational programme 
held in 4th quarter 2006
290 23.4 11.7
After educational programme held 
in 4th quarter 2006
250 43.6 39.6
After educational programme held 
in 2nd quarter 2007
226 63.7 57.1BMC Infectious Diseases 2009, 9:70 http://www.biomedcentral.com/1471-2334/9/70
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control interventions may be the molecular heterogeneity
of P. aeruginosa outbreaks. Thus, the timely identification
of increased isolation of this pathogen, achieved by
means of active surveillance, appears to be crucial to limit
the spreading of P. aeruginosa in NICU settings.
Conclusion
This study suggests that an infection control programme
based on active surveillance and strict adherence to hand
disinfection and gloves use policies and supported by
environmental sampling and molecular analysis is effec-
tive in controlling NICU multi-clone P. aeruginosa out-
breaks.
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